Literature DB >> 12793966

Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.

Eric E Smith1, Steven M Greenberg.   

Abstract

Cerebral amyloid angiopathy is a disorder in which deposition of amyloid within the arterial media and adventitia leads to intracerebral hemorrhage. Diagnosis during life has been hampered by the requirement for post-mortem examination for definitive diagnosis. The Boston Criteria for the diagnosis of cerebral amyloid angiopathy-related hemorrhage were developed in 1995 and 1996 in order to meet the need for a standardized set of diagnostic criteria that can be applied to living patients. Using a combination of clinical, radiologic, and pathologic data, these criteria reliably differentiate lobar intracerebral hemorrhage into categories of possible, probable, or definite based on the likelihood of underlying cerebral amyloid angiopathy. These criteria will be crucial for disease classification for future clinical studies.

Entities:  

Mesh:

Year:  2003        PMID: 12793966     DOI: 10.1007/s11883-003-0048-4

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  45 in total

1.  Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage.

Authors:  R D Bailey; R G Hart; O Benavente; L A Pearce
Journal:  Neurology       Date:  2001-03-27       Impact factor: 9.910

2.  Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy.

Authors:  S M Greenberg; J P Vonsattel; A Z Segal; R I Chiu; A E Clatworthy; A Liao; B T Hyman; G W Rebeck
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

3.  Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan.

Authors:  J Masuda; K Tanaka; K Ueda; T Omae
Journal:  Stroke       Date:  1988-02       Impact factor: 7.914

4.  Age-related spontaneous intracerebral hematoma in a German community.

Authors:  H Schütz; R H Bödeker; M Damian; P Krack; W Dorndorf
Journal:  Stroke       Date:  1990-10       Impact factor: 7.914

5.  The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage.

Authors:  M O McCarron; J A Nicoll; J Stewart; J W Ironside; D M Mann; S Love; D I Graham; D Dewar
Journal:  J Neuropathol Exp Neurol       Date:  1999-07       Impact factor: 3.685

6.  Cerebral amyloid angiopathy presenting as a brain mass.

Authors:  A K Osumi; R D Tien; G J Felsberg; M Rosenbloom
Journal:  AJNR Am J Neuroradiol       Date:  1995-04       Impact factor: 3.825

7.  Petechial hemorrhages accompanying lobar hemorrhage: detection by gradient-echo MRI.

Authors:  S M Greenberg; S P Finklestein; P W Schaefer
Journal:  Neurology       Date:  1996-06       Impact factor: 9.910

8.  Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes.

Authors:  H V Vinters; J J Gilbert
Journal:  Stroke       Date:  1983 Nov-Dec       Impact factor: 7.914

9.  Lobar cerebral hemorrhages: acute clinical syndromes in 26 cases.

Authors:  A H Ropper; K R Davis
Journal:  Ann Neurol       Date:  1980-08       Impact factor: 10.422

10.  High frequency of apolipoprotein E epsilon 2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhage.

Authors:  M O McCarron; J A Nicoll
Journal:  Neurosci Lett       Date:  1998-05-08       Impact factor: 3.046

View more
  23 in total

Review 1.  Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates.

Authors:  Jeremy D Schmahmann; Eric E Smith; Florian S Eichler; Christopher M Filley
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 2.  Cerebral microbleeds and macrobleeds: should they influence our recommendations for antithrombotic therapies?

Authors:  Kellen E Haley; Steven M Greenberg; M Edip Gurol
Journal:  Curr Cardiol Rep       Date:  2013-12       Impact factor: 2.931

Review 3.  Emerging concepts in sporadic cerebral amyloid angiopathy.

Authors:  Andreas Charidimou; Gregoire Boulouis; M Edip Gurol; Cenk Ayata; Brian J Bacskai; Matthew P Frosch; Anand Viswanathan; Steven M Greenberg
Journal:  Brain       Date:  2017-07-01       Impact factor: 13.501

4.  Cerebral amyloid angiopathy revealed by rapidly progressing leptomeningeal lesions.

Authors:  Armelle Chouraki; Adeline Rollin-Sillaire; Vincent Deramecourt; Fahed Zairi; Emilie Le Rhun; Charlotte Cordonnier; Christine Delmaire; Claude-Alain Maurage; Florence Pasquier
Journal:  J Neurol       Date:  2014-05-25       Impact factor: 4.849

5.  Statin use following intracerebral hemorrhage: a decision analysis.

Authors:  M Brandon Westover; Matt T Bianchi; Mark H Eckman; Steven M Greenberg
Journal:  Arch Neurol       Date:  2011-01-10

Review 6.  Imaging small vessel-associated white matter changes in aging.

Authors:  D H Salat
Journal:  Neuroscience       Date:  2013-12-06       Impact factor: 3.590

Review 7.  Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta-analysis.

Authors:  Andreas Charidimou; Jan O Friedrich; Steven M Greenberg; Anand Viswanathan
Journal:  Neurology       Date:  2018-01-31       Impact factor: 9.910

Review 8.  Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Authors:  Piotr Lewczuk; Peter Riederer; Sid E O'Bryant; Marcel M Verbeek; Bruno Dubois; Pieter Jelle Visser; Kurt A Jellinger; Sebastiaan Engelborghs; Alfredo Ramirez; Lucilla Parnetti; Clifford R Jack; Charlotte E Teunissen; Harald Hampel; Alberto Lleó; Frank Jessen; Lidia Glodzik; Mony J de Leon; Anne M Fagan; José Luis Molinuevo; Willemijn J Jansen; Bengt Winblad; Leslie M Shaw; Ulf Andreasson; Markus Otto; Brit Mollenhauer; Jens Wiltfang; Martin R Turner; Inga Zerr; Ron Handels; Alexander G Thompson; Gunilla Johansson; Natalia Ermann; John Q Trojanowski; Ilker Karaca; Holger Wagner; Patrick Oeckl; Linda van Waalwijk van Doorn; Maria Bjerke; Dimitrios Kapogiannis; H Bea Kuiperij; Lucia Farotti; Yi Li; Brian A Gordon; Stéphane Epelbaum; Stephanie J B Vos; Catharina J M Klijn; William E Van Nostrand; Carolina Minguillon; Matthias Schmitz; Carla Gallo; Andrea Lopez Mato; Florence Thibaut; Simone Lista; Daniel Alcolea; Henrik Zetterberg; Kaj Blennow; Johannes Kornhuber
Journal:  World J Biol Psychiatry       Date:  2017-10-27       Impact factor: 4.132

9.  Incidence of symptomatic hemorrhage in patients with lobar microbleeds.

Authors:  Ellis S van Etten; Eitan Auriel; Kellen E Haley; Alison M Ayres; Anastasia Vashkevich; Kristin M Schwab; Jonathan Rosand; Anand Viswanathan; Steven M Greenberg; M Edip Gurol
Journal:  Stroke       Date:  2014-06-19       Impact factor: 7.914

10.  Diffuse white matter loss in a transgenic rat model of cerebral amyloid angiopathy.

Authors:  Hedok Lee; Feng Xu; Xiaodan Liu; Sunil Koundal; Xiaoyue Zhu; Judianne Davis; David Yanez; Joseph Schrader; Aleksandra Stanisavljevic; Douglas L Rothman; Joanna Wardlaw; William E Van Nostrand; Helene Benveniste
Journal:  J Cereb Blood Flow Metab       Date:  2020-08-13       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.